Genevant Sciences GmbH

General

Total Cases4

Active Cases2

Patents--

CourtsD. New Jersey D. Delaware S.D. New York

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/06/24	Arbutus Pharma Corp v. Pfizer Inc 3:23-CV-01876 ( D. NJ )	Set Deadlines as to [146] MOTION to Seal . Motion set for 10/7/2024 before Magistrate Judge Tonianne J. Bongiovanni. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (jdg) (Entered: 09/06/2024) Set Deadlines as to [146] MOTION to Seal . Motion set for 10/7/2024 before Magistrate Judge Tonianne J. Bongiovanni. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (jdg) (Entered: 09/06/2024)
09/05/24	Arbutus Pharma Corp v. Pfizer Inc 3:23-CV-01876 ( D. NJ )	MOTION to Seal by PFIZER INC.. (Attachments: # [1] Proposed Findings of Fact and Conclusions of Law, # [2] Declaration of Liza M. Walsh with Ex. 1, # [3] Statement in Lieu of Brief, # [4] Text of Proposed Order)(WALSH, LIZA) (Entered: 09/05/2024)
09/05/24	Arbutus Pharma Corp v. Pfizer Inc 3:23-CV-01876 ( D. NJ )	REDACTION to [131] Letter,, by PFIZER INC.. (WALSH, LIZA) (Entered: 09/05/2024)
09/05/24	Arbutus Pharma Corp v. Pfizer Inc 3:23-CV-01876 ( D. NJ )	REDACTION to [128] Letter,, by PFIZER INC.. (WALSH, LIZA) (Entered: 09/05/2024)
09/05/24	Arbutus Pharma Corp v. Pfizer Inc 3:23-CV-01876 ( D. NJ )	REDACTION to [129] Letter,, by ARBUTUS PHARMA CORP., GENEVANT SCIENCES GMBH. (CALMANN, ARNOLD) (Entered: 09/05/2024)
09/03/24	Arbutus Pharma Corp v. Pfizer Inc 3:23-CV-01876 ( D. NJ )	TEXT ORDER: Please take notice that an in-person Markman Hearing is hereby scheduled for 12/18/2024 at 10:30AM in Trenton- Courtroom 4W. So Ordered by Judge Zahid N. Quraishi on 9/3/2024. (kas) (Entered: 09/03/2024)
08/30/24	Arbutus Pharma Corp v. Pfizer Inc 3:23-CV-01876 ( D. NJ )	Letter from Arnold B. Calmann, Esq., on behalf of the Parties, to the Honorable Zahid N. Quraishi, U.S.D.J., Regarding Scheduling of Markman Hearing Pursuant to L. Pat. R. 4.6. (CALMANN, ARNOLD) (Entered: 08/30/2024)
08/26/24	Arbutus Biopharma Corp v. Moderna Inc 1:22-CV-00252 ( D. DE )	Official Transcript of Telephonic Status Conference held on 8/15/2024 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber Coleen Rand, Email: RedDoor Legal Services, LLC (973)-985-3668. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 9/16/2024. Redacted Transcript Deadline set for 9/26/2024. Release of Transcript Restriction set for 11/25/2024. (mpb) (Entered: 08/26/2024) Official Transcript of Telephonic Status Conference held on 8/15/2024 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber Coleen Rand, Email: RedDoor Legal Services, LLC (973)-985-3668. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 9/16/2024. Redacted Transcript Deadline set for 9/26/2024. Release of Transcript Restriction set for 11/25/2024. (mpb) (Entered: 08/26/2024)
08/26/24	Arbutus Biopharma Corp v. Moderna Inc 1:22-CV-00252 ( D. DE )	STIPULATION AND ORDER granting D.I. [402] Stipulation to Extend Time. The deadline for the completion of fact discovery relating to the subpoenas to Lonza Biologics, Inc., Catalent Indiana, LLC; Patheon Manufacturing Services, LLC, and Baxter Pharmaceutical Solutions, LLC is extended through and including September 27, 2024. Signed by Judge Mitchell S. Goldberg on 8/26/2024. (mpb) (Entered: 08/26/2024) STIPULATION AND ORDER granting D.I. [402] Stipulation to Extend Time. The deadline for the completion of fact discovery relating to the subpoenas to Lonza Biologics, Inc., Catalent Indiana, LLC; Patheon Manufacturing Services, LLC, and Baxter Pharmaceutical Solutions, LLC is extended through and including September 27, 2024. Signed by Judge Mitchell S. Goldberg on 8/26/2024. (mpb) (Entered: 08/26/2024)
08/26/24	Arbutus Biopharma Corp v. Moderna Inc 1:22-CV-00252 ( D. DE )	STIPULATION AND ORDER granting D.I. 402 Stipulation to Extend Time. The deadline for the completion of fact discovery relating to the subpoenas to Lonza Biologics, Inc., Catalent Indiana, LLC; Patheon Manufacturing Services, LLC, and Baxter Pharmaceutical Solutions, LLC is extended through and including September 27, 2024. Signed by Judge Mitchell S. Goldberg on 8/26/2024. (mpb) (Entered: 08/26/2024) STIPULATION AND ORDER granting D.I. 402 Stipulation to Extend Time. The deadline for the completion of fact discovery relating to the subpoenas to Lonza Biologics, Inc., Catalent Indiana, LLC; Patheon Manufacturing Services, LLC, and Baxter Pharmaceutical Solutions, LLC is extended through and including September 27, 2024. Signed by Judge Mitchell S. Goldberg on 8/26/2024. (mpb) (Entered: 08/26/2024)